Cadwell Industries Launch Neuromuscular Ultrasound Device
Offering a variety of enhanced features for image optimization and improved workflow efficiencies, the Sierra NMUS1 device reportedly includes the first software specifically designed for neuromuscular ultrasound applications.
Providing an array of benefits to bolster image quality and workflow efficiencies, the newly launched Sierra NMUS1™ combines neuromuscular ultrasound imaging with electrodiagnostic testing capabilities.
Featuring software specifically tailored to neuromuscular ultrasound, the Sierra NMUS1 device (Cadwell Industries) enables clinicians to access improved image quality through edge enhancement, advanced speckle reduction and spatial compounding, according to the company.
Cadwell Industries said the Sierra NMUS1 device offers three probes, a C-5-2 Curvilinear Probe, an L14-4 Linear Probe, and an HL18-4 Linear Hockey Stick Probe, that facilitate needle visualization and enhanced image quality. The neuromuscular ultrasound device also includes upgraded Sierra® 4 software with advanced artifact reduction and trace resolution, according to Cadwell Industries.
Through the Sierra 4 software, the Sierra NMUS1 device integrates electromyography (EMG) and nerve conduction studies (NCS). Other efficiencies of the Sierra NMUS1 system include automated labeling of images and results, easy measurement and annotation of images; and report generation that allows clinicians to document electrodiagnostic and imaging findings in one report, according to Cadwell Industries.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
